CAR T Therapy May Cause Rare Cancer & How CRISPR Could Be The Solution

CAR T therapy safety falls into question as the FDA investigates reports of rare T cell lymphoma after treatment. This concern could be resolved with CRISPR technology.

Related Keywords

United States ,United Kingdom , ,Possible Solution ,Cart Therapy ,Crispr ,Gene Editing ,Gene Transduction ,Leukemia ,Lymphoma ,Fda ,Insertional Mutagenesis ,Retrovirus ,Lentivirus ,